Loading
Mannkind Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Castagna Michael, was filed 10 Mar 2026.
Insider Decl.
434
Thresholds
n/a
Buy Volume
€2M
74 ops. · all time
Sell Volume
€10M
62 ops. · all time
Who traded when
BuySaleSteven B. Binder10 sales
David Thomson5 sales
Michael Castagna1 buy4 sales
Stuart A. Tross3 sales
Sanjay R. Singh1 sale
Since the insiders bought
- +26.6%Entry US$2.82 · Close at T+90 US$3.57
- +16.5%Entry US$3.94 · Close at T+365 US$4.59
- +16.5%Entry US$3.94 · Close at T+365 US$4.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Mannkind Corp Strong Buy (bullish), based on 9 analysts. Average price target: US$8.08.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,238 of 26,234 companies
38.5
score / 100
Value32
Quality45
FCF yld1.4%
Earn yld0.6%
EV/EBITDA26.2x
ROE·
Gross mgn75%
Net mgn1.7%
Debt/EBITDA7.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$3.05
Analyst consensus
9 analystsStrong buy
US$4.75Target US$8.08(+165%)US$13.00
Income statement
RevenueUS$349M
Gross profitUS$261M75% margin
EBITDAUS$51.5M15% margin
Net incomeUS$5.9M-11.1% margin
Valuation
PER (forward)22.6x
Beta1.08
Balance sheet & cash
Market capUS$980.7M
Total debtUS$367.4M
Free Cash FlowUS$13.7M
Profitability & ownership
ROA0.8%
% insiders1.5%
% institutions57.1%
Last declaration on 28 September 2026
Declarations434 total
39,051 shares@ US$3.290.012% mcap2.4% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-405736:0
39,051 shares@ US$3.290.013% mcap20.8% of flowCommonSEC144:0001950047-26-009820
33,558 shares@ US$3.810.012% mcap2.2% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-391003:0
33,558 shares@ US$3.940.013% mcap20.9% of flowCommonSEC144:0001950047-26-009303
39,051 shares@ US$4.060.015% mcap3.0% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-343016:0
39,051 shares@ US$3.890.014% mcap24.2% of flowCommonSEC144:0001950047-26-007817
52,485 shares@ US$4.040.020% mcap34.1% of flowCommonSEC144:0001950047-26-007190
24,109 shares@ US$4.040.0090% mcap100.0% of flowCommonSEC144:0001950047-26-007191
4,634 shares@ US$4.090.0018% mcap0.4% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308129:3
93,790 shares0Common Stock, $0.01 Par ValueSEC:0001193125-26-308129:0
350,260 shares0Common Stock, $0.01 Par ValueSEC:0001193125-26-308133:0
93,790 shares0Common Stock, $0.01 Par ValueSEC:0001193125-26-308134:0
93,790 shares0Common Stock, $0.01 Par ValueSEC:0001193125-26-308131:0
70,550 shares0Common Stock, $0.01 Par ValueSEC:0001193125-26-308132:0
17,754 shares@ US$4.090.0067% mcap2.1% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308131:3
15,688 shares@ US$4.090.0059% mcap1.2% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308129:1
4,073 shares@ US$4.090.0015% mcap0.3% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308129:2
52,485 shares@ US$4.060.020% mcap4.1% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308129:4
192,819 shares@ US$4.090.073% mcap8.0% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308133:1
63,996 shares@ US$4.090.024% mcap2.7% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308133:3
58,904 shares@ US$4.090.022% mcap2.5% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308133:4
12,662 shares@ US$4.090.0048% mcap1.5% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308131:2
16,378 shares@ US$4.090.0062% mcap1.9% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308131:4
24,109 shares@ US$4.050.0090% mcap2.8% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308131:5
22,047 shares@ US$4.090.0084% mcap22.1% of flowCommon Stock, $0.01 Par ValueSEC:0001193125-26-308132:1
25 of 434 declarations
About Mannkind Corp
At Mannkind Corp, 74 purchases make up 54% of open-market trades, but they are small: EUR 2.40 million in total, with a median of EUR 5,376, 61 filings of them flagged as clustered. From January 31 to February 28, 2022, 7 filers bought for EUR 655,253. Kent Kresa, Director, bought EUR 844,842 on October 13, 2017; Jennifer Grancio, Director, EUR 268,311 on February 28, 2022; Michael Castagna, Chief Executive Officer, EUR 222,945 on March 10, 2026. For the 73 purchases with a stored result, the 90-day median is 6.7%, with 56% positive (recorded past results, not a forecast).
The 62 sales come to EUR 9.84 million (median EUR 93,175). David Thomson, EVP Genl Counsel & Secretary, sold EUR 709,130 on December 2, 2025; Castagna EUR 653,974 on May 24, 2023 and EUR 517,860 on December 2, 2025.
Read moreShow less
Castagna is the top filer, with 102 filings (25 purchases, 23 sales), ahead of Stuart A. Tross, Chief People & Workpl Officer (65) and Steven B. Binder, Director (62). The 434 filings, published from February 29, 2016 to September 28, 2026, include 273 grants. Annual volume reaches 77 in 2024, against 15 in 2018. Last twelve months: 61 filings, 1 purchase, 12 sales. The US healthcare and pharma company is listed on Nasdaq and worth USD 993.6 million.
